<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000388.v1.p1" parentStudy="phs000388.v1.p1" createDate="2011-08-03" modDate="2011-09-13">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Erwin P. Bottinger</td><td>Charles R. Bronfman Institute for Personalized Medicine, Mount Sinai School of Medicine, New York, NY, USA</td></tr>
		<tr><td>Funding Source</td><td>IPM BioBank (GCO:09-0148)</td><td>Mount Sinai School of Medicine, New York, NY, USA</td></tr>
		<tr><td>Genotyping Center</td><td>Affymetrix Research Sevices Laboratory (ARSL)</td><td>Affymetrix, Santa Clara, CA, USA</td></tr>
		<tr><td>Funding Source for Genotyping</td><td>IPM BioBank (GCO:09-0148)</td><td>Mount Sinai School of Medicine, New York, NY, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>IPM BioBank GWAS</StudyNameEntrez>
	<StudyNameReportPage>Charles R. Bronfman Institute for Personalized Medicine (IPM) BioBank Genome Wide Association Study of Cardiovascular, Renal and Metabolic Phenotypes</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The Institute for Personalized Medicine (IPM) Biobank Project is a consented, EMR-linked medical care setting biorepository     of the Mount Sinai Medical Center (MSMC) drawing from a population of over 70,000 inpatients and 800,000 outpatient visits     annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86% African American),     East Harlem (88% Hispanic Latino), and Upper East Side (88% Caucasian/white) with broad health disparities. IPM Biobank     populations include 28% African American (AA), 38% Hispanic Latino (HL) predominantly of Caribbean origin, 23% Caucasian/White (CW).     IPM Biobank disease burden is reflective of health disparities with broad public health impact: average body mass index     of 28.9 and frequencies of hypertension (55%), hypercholesterolemia (32%), diabetes (30%), coronary artery disease (25%),     chronic kidney disease (23%), among others. Biobank operations are fully integrated in clinical care processes, including     direct recruitment from clinical sites, waiting areas and phlebotomy stations by dedicated Biobank recruiters independent of     clinical care providers, prior to or following a clinician standard of care visit. Recruitment currently occurs at a broad     spectrum of over 30 clinical care sites.</p>     <p>Minorities are strikingly underrepresented in GWAS, including Coronary Artery Disease (CAD) and Chronic Kidney Disease;     multigenic genetic risk scores for CAD have been recently validated in European ancestry populations, but not in AA or HL populations.     Several important opportunities exist for extending additional GWAS to minority populations with a shared risk spectrum of CAD and CKD.     For example, progressive CKD is a major and independent risk factor for CVD with an inverse relationship between estimated GFR (eGFR),     and risk for mortality and cardiovascular events. This increased risk is only partially explained by the prevalence of cardiovascular     risk factors among these patients.</p>     <p>We conducted a GWAS of CAD and CKD related phenotypes in IPM Biobank with the primary objective to explore the genetics of     overlapping CAD and CKD predominantly in minority populations characterized by increased risk.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Cases and controls for each of the relevant phenotypes were initially selected using electronic case definition algorithms (CDA&#39;s)     for CAD, CKD, hypertension (created by IPM e-phenotyping team) and T2DM and lipids (modified from eMERGE phase I CDA&#39;s) applied     to the IPM Biobank. Age filters were applied: (cases &lt;66; controls &gt;59). This was followed by expert physician review of every     case/control classification. As such, every case and every control in our sample has been validated by an expert physician reviewer.     Population distributions in both cases and controls are consistent with those of our Biobank and as such, of our local     population (AA~25%, EA~25%, HL~40%).</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="21573225"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Coronary Artery Disease"/>
		<Disease vocab_source="MESH" vocab_term="Chronic Kidney Failure"/>
		<Disease vocab_source="MESH" vocab_term="Diabetes Mellitus, Type 2"/>
		<Disease vocab_source="MESH" vocab_term="Hypertension"/>
		<Disease vocab_source="MESH" vocab_term="Dyslipidemias"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Erwin P. Bottinger</AttName>
			<Institution>Charles R. Bronfman Institute for Personalized Medicine, Mount Sinai School of Medicine, New York, NY, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>IPM BioBank (GCO:09-0148)</AttName>
			<Institution>Mount Sinai School of Medicine, New York, NY, USA</Institution>
		</Header>
		<Header title="Genotyping Center">
			<AttName>Affymetrix Research Sevices Laboratory (ARSL)</AttName>
			<Institution>Affymetrix, Santa Clara, CA, USA</Institution>
		</Header>
		<Header title="Funding Source for Genotyping">
			<AttName>IPM BioBank (GCO:09-0148)</AttName>
			<Institution>Mount Sinai School of Medicine, New York, NY, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="eMERGE" url="https://www.mc.vanderbilt.edu/victr/dcc/projects/acc/index.php/About"/>
	</StudyURLs>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="HR_MSSM" longName="Health Research - MSSM"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHGRI</DacName>
      <DacFullName>National Human Genome Research Institute</DacFullName>
      <DacEmail>nhgridac@mail.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>301-480-2770</DacFax>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000388.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000388.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000388.v1.p1" FileName="eMERGE_GWAS_DUC_09-23-2011.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Health Research - MSSM</ConsentName>
        <ConsentAbbrev>HR_MSSM</ConsentAbbrev>
        <UseLimitation>Health Research (HR), may be used for genetic studies to learn about, prevent, or treat health problems.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd003650.1" type="protocol" createDate="2011-08-09" modDate="2011-08-25" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003650.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000388.v1.p1&amp;phd=3650">
      <OrigName>CAD Case Algorithm.pdf</OrigName>
      <DisplayName>Coronary Artery Disease Case Definition Algorithm</DisplayName>
      <Description>Coronary Artery Disease Case Definition Algorithm</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003651.1" type="protocol" createDate="2011-08-09" modDate="2011-08-25" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003651.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000388.v1.p1&amp;phd=3651">
      <OrigName>CKD Case Algorithm.pdf</OrigName>
      <DisplayName>Chronic Kidney Disease Case Definition Algorithm</DisplayName>
      <Description>Chronic Kidney Disease Case Definition Algorithm</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003652.1" type="protocol" createDate="2011-08-09" modDate="2011-08-25" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003652.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000388.v1.p1&amp;phd=3652">
      <OrigName>Hypertension Case Algorithm.pdf</OrigName>
      <DisplayName>Hypertension Case Definition Algorithm</DisplayName>
      <Description>Hypertension Case Definition Algorithm</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003653.1" type="protocol" createDate="2011-08-09" modDate="2011-08-25" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003653.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000388.v1.p1&amp;phd=3653">
      <OrigName>Lipids Case Algorithm.pdf</OrigName>
      <DisplayName>Lipids Case Definition Algorithm</DisplayName>
      <Description>Lipids Case Definition Algorithm</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003654.1" type="protocol" createDate="2011-08-09" modDate="2011-08-25" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003654.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000388.v1.p1&amp;phd=3654">
      <OrigName>T2D Case Algorithm.pdf</OrigName>
      <DisplayName>Type 2 Diabetes Case Definition Algorithm</DisplayName>
      <Description>Type 2 Diabetes Case Definition Algorithm</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
    <Document phd="phd003697.1" type="protocol" createDate="2011-09-12" modDate="2011-09-12" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003697.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000388.v1.p1&amp;phd=3697">
      <OrigName>QC measures.docx</OrigName>
      <DisplayName>Quality Control Measures</DisplayName>
      <Description>Quality Control Measures</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>

  <Annotations>
    <DocumentPart phd="phd003650.1" sectionId="sec1">
      <phvList>
        <phvRef variableId="162683"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003651.1" sectionId="sec1">
      <phvList>
        <phvRef variableId="162682"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003652.1" sectionId="sec1">
      <phvList>
        <phvRef variableId="162686"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003653.1" sectionId="sec1">
      <phvList>
        <phvRef variableId="162685"/>
      </phvList>
    </DocumentPart>
    <DocumentPart phd="phd003654.1" sectionId="sec1">
      <phvList>
        <phvRef variableId="162684"/>
      </phvList>
    </DocumentPart>
  </Annotations>



</Study>

</Studies>

</GaPExchange>
